Petros Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Petros Pharmaceuticals is holding a special meeting to seek stockholder approval for several key proposals, including a share issuance related to recent warrants, a reverse stock split, and an amendment to their incentive compensation plan.
OTC.Pink
DEFA14A: Petros Pharmaceuticals Engages Proxy Solicitor and Corrects Vote Count Ahead of Annual Meeting
Petros Pharmaceuticals has hired Campaign Management LLC to solicit proxies for its upcoming annual meeting and corrected the vote count for its Series A Preferred Stock.
OTC.Pink
Petros Pharmaceuticals is holding its 2024 annual meeting of stockholders on November 20, 2024, to vote on key proposals including a reverse stock split, director elections, and executive compensation.